These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
243 related items for PubMed ID: 22196973
1. Effective prevention of Pseudomonas aeruginosa cross-infection at a cystic fibrosis centre - results of a 10-year prospective study. Wiehlmann L, Cramer N, Ulrich J, Hedtfeld S, Weissbrodt H, Tümmler B. Int J Med Microbiol; 2012 Mar; 302(2):69-77. PubMed ID: 22196973 [Abstract] [Full Text] [Related]
4. Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center. Campana S, Taccetti G, Ravenni N, Masi I, Audino S, Sisi B, Repetto T, Döring G, de Martino M. J Cyst Fibros; 2004 Aug; 3(3):159-63. PubMed ID: 15463902 [Abstract] [Full Text] [Related]
5. Environmental contamination with an epidemic strain of Pseudomonas aeruginosa in a Liverpool cystic fibrosis centre, and study of its survival on dry surfaces. Panagea S, Winstanley C, Walshaw MJ, Ledson MJ, Hart CA. J Hosp Infect; 2005 Feb; 59(2):102-7. PubMed ID: 15620443 [Abstract] [Full Text] [Related]
10. A 1-m distance is not safe for children with cystic fibrosis at risk for cross-infection with Pseudomonas aeruginosa. Festini F, Taccetti G, Galici V, Neri S, Bisogni S, Ciofi D, Braggion C. Am J Infect Control; 2010 Apr; 38(3):244-5. PubMed ID: 20129701 [Abstract] [Full Text] [Related]
12. Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients. Schelstraete P, Van Daele S, De Boeck K, Proesmans M, Lebecque P, Leclercq-Foucart J, Malfroot A, Vaneechoutte M, De Baets F. Eur Respir J; 2008 Apr; 31(4):822-9. PubMed ID: 18094014 [Abstract] [Full Text] [Related]
13. Epidemiology of Pseudomonas aeruginosa in a cystic fibrosis rehabilitation centre. Van Daele SG, Franckx H, Verhelst R, Schelstraete P, Haerynck F, Van Simaey L, Claeys G, Vaneechoutte M, de Baets F. Eur Respir J; 2005 Mar; 25(3):474-81. PubMed ID: 15738291 [Abstract] [Full Text] [Related]
14. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. Burns JL, Gibson RL, McNamara S, Yim D, Emerson J, Rosenfeld M, Hiatt P, McCoy K, Castile R, Smith AL, Ramsey BW. J Infect Dis; 2001 Feb 01; 183(3):444-52. PubMed ID: 11133376 [Abstract] [Full Text] [Related]
15. Different opinions of physicians on the importance of measures to prevent acquisition of Pseudomonas aeruginosa from the environment. Steinkamp G, Ullrich G. J Cyst Fibros; 2003 Dec 01; 2(4):199-205. PubMed ID: 15463874 [Abstract] [Full Text] [Related]
19. High genotypic diversity of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis in the Czech Republic. Vosahlikova S, Drevinek P, Cinek O, Pohunek P, Maixnerova M, Urbaskova P, van den Reijden TJ, Dijkshoorn L, Nemec A. Res Microbiol; 2007 May 01; 158(4):324-9. PubMed ID: 17448645 [Abstract] [Full Text] [Related]
20. Defining routes of airborne transmission of Pseudomonas aeruginosa in people with cystic fibrosis. Clifton IJ, Peckham DG. Expert Rev Respir Med; 2010 Aug 01; 4(4):519-29. PubMed ID: 20658913 [Abstract] [Full Text] [Related] Page: [Next] [New Search]